Sohini Das &Amp; Samreen Ahmad

Stories by Sohini Das &Amp; Samreen Ahmad

WFH rules simplified! More jobs for small town India

WFH rules simplified! More jobs for small town India

Rediff.com   23 Nov 2020

Tier-II and tier-III towns have a reason to rejoice.

Byju's raises $200 mn in fresh funding; valuation surges to $12 bn

Byju's raises $200 mn in fresh funding; valuation surges to $12 bn

Rediff.com   23 Nov 2020

While BlackRock is an existing investor in Byju's, T Rowe joined as a new investor.

PUBG to return to India with new game, $100 mn investment, better security

PUBG to return to India with new game, $100 mn investment, better security

Rediff.com   13 Nov 2020

The company is also planning to create an Indian subsidiary to enhance communications and services with players for which it will hire over 100 employees specialising in business, e-sports, and game development.

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com   13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Rediff.com   4 Nov 2020

Siemens Healthineers, one of the largest manufacturers of made-in-India CT scanners, has sold 80-100 such machines in the last 45 days. The medical technology firm typically sells 250 machines in a year.

How start-ups are helping kirana stores go digital to manage business

How start-ups are helping kirana stores go digital to manage business

Rediff.com   4 Nov 2020

Start-ups such as Max Wholesale, Jumbotail and ShopKirana are helping them place orders, maintain inventory, optimise delivery routes and make payments, all digitally.

Bharat Biotech starts Covaxin's at-risk manufacture

Bharat Biotech starts Covaxin's at-risk manufacture

Rediff.com   2 Nov 2020

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.

How Indus, the Made in India app store, took wing

How Indus, the Made in India app store, took wing

Rediff.com   29 Oct 2020

The content discovery platform designed to help you discover content and services in the language of your choice recently turned profitable. It has delivered 1 billion application installs and updates in the past 12 months, says Samreen Ahmad.

Looking to go omnichannel, BigBasket may seal deal with Tatas

Looking to go omnichannel, BigBasket may seal deal with Tatas

Rediff.com   29 Oct 2020

The competition which BigBasket faces now is with the big three - Amazon, Walmart, and Reliance.

Why Dr Reddy's had to shut all its units

Why Dr Reddy's had to shut all its units

Rediff.com   25 Oct 2020

Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.

Covid-19 impact: Low interest loans likely for vaccine companies

Covid-19 impact: Low interest loans likely for vaccine companies

Rediff.com   10 Oct 2020

While there has been no commitment from the government on the procurement of vaccines, initial volumes, or distribution plans, there is a likelihood that the low interest loans may be made available to these players only when the time to scale up manufacturing arises.

Covaxin: How Bharat Biotech plans to boost immunity

Covaxin: How Bharat Biotech plans to boost immunity

Rediff.com   6 Oct 2020

Adjuvants may be added to a vaccine to produce more antibodies and longer lasting immunity thus minimising the dose of antigen needed.

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com   6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com   6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Silver Lake's love affair with India continues

Silver Lake's love affair with India continues

Rediff.com   25 Sep 2020

The PE biggie has committed to pumping money into Jio Platforms, Byju's and Reliance Retail so far this year - all marquee names in their respective sectors.

Covid spurs matured-stage start-ups to advance their IPO plans

Covid spurs matured-stage start-ups to advance their IPO plans

Rediff.com   25 Sep 2020

In the past few days, many companies, including fashion e-tailer Nykaa, food delivery platform Zomato, logistics and delivery firm Delhivery, insurance discovery platform PolicyBazaar, eyewear retail chain Lenskart, and edtech and online tutoring firm Byju's, have openly spoken about their IPO plans.

How India is gearing up to distribute Covid-19 vaccine

How India is gearing up to distribute Covid-19 vaccine

Rediff.com   18 Sep 2020

A model being considered is to have a combined cold chain approach - where the agricultural cold chain would be combined with vaccine cold chains.

Tiger Global, others invest $225 mn in parent of IPL title sponsor Dream11

Tiger Global, others invest $225 mn in parent of IPL title sponsor Dream11

Rediff.com   15 Sep 2020

The new round values the company at $2.5 billion, more than double the over $1 billion valuation Dream 11 enjoyed in April 2019 when it was declared the country's first gaming unicorn.

How Covid has triggered wave of innovations in India

How Covid has triggered wave of innovations in India

Rediff.com   14 Sep 2020

Some of these items of consumption include ultraviolet disinfectants and sanitising boxes, free-finger touch devices, do-it-yourself grooming kits, self-cleaning water bottles, smart tiffin boxes, hand-sanitizer wearables, antiviral fabrics, tiles, flooring and mattresses, and anti-fogging glasses.

Labs bet on Covid tests for next growth phase

Labs bet on Covid tests for next growth phase

Rediff.com   14 Sep 2020

The bouquet of Covid-19 tests that most diagnostic labs are offering include antibody tests (blood tests), rapid antigen tests (point of care tests that detect the presence of an antigen from a nasal or throat swab in case of SARS-CoV-2), and reverse transcription-polymerase chain reaction (RT-PCR) tests.